Theremia

AI-driven platform to design drug derivatives with improved efficacy across diverse demographics.
Founded 2024
Founders Iris Maréchal, CEO Chloé Geoffroy, CTO
AiBiotechnologyHealthcare
View Website

AI-driven platform to design drug derivatives with improved efficacy across diverse demographics. For blockbuster drugs about to expire, Theremia’s solution is pharma companies’ only chance to protect their revenue.

Founders

Iris
Maréchal

CEO

Iris is a former BCG consultant who has worked with some of the world’s leading pharma companies. As a student, she founded a nonprofit to national scale.

Linkedin

Chloé
Geoffroy

CTO

Chloé is a Pharmacist and Chemical Engineer with a PhD and post-doc from École Normale Supérieure in Neuropharmacology.

Linkedin

Milestones

2024

Founded at Entrepreneur First

Seed (€3 million) led by Eurazeo and Salica Investment

Related

Ai Biotechnology Healthcare
A&B Smart Materials

A&B Smart Materials

Revolutionising cooling technology through the development of novel, smart hydrogels.
Climate or EnvironmentEnergySustainability
AarogyaAI

AarogyaAI

AarogyaAI is an AI-enabled SaaS that diagnoses drug-resistant turberculosis (DR-TB) in hours instead of weeks.
Healthcare
AccuRx

AccuRx

Powering communications in the healthcare sector.
Healthcare
Ackcio

Ackcio

Extremely reliable, wireless monitoring solutions for the world's most challenging industries.
Manufacturing or Industrial
Adelántalo

Adelántalo

Factoring 2.0 for Trucking in LATAM.
B2BFinanceSupply Chain, Transportation or Logistics
Affable

Affable

Leverage AI for your Influencer Marketing Campaigns.
Advertising/Marketing